CROSSJECT (STU:74C) FFO


STU:74C CROSSJECT STU:74C
48 GF Score
Price €1.77
GF Value €1.18
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is CROSSJECT FFO?

FFO (Funds from operations) only applies to REITs.

STU:74C
48GF Score
CROSSJECT STU:74C
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is CROSSJECT (STU:74C) Overvalued in 2026?

Based on GuruFocus' analysis, CROSSJECT stock appears to be overvalued. The current stock price of €1.77 is trading 49.8% above its estimated GF Value™ of €1.18. GuruFocus considers CROSSJECT to be Significantly Overvalued.

Key valuation signals for STU:74C:

  • FFO:
  • GF Value™: €1.18 vs. price of €1.77 (49.8% above fair value)
  • GF Score™: 48/100 with 4 warning signs

No single metric tells the full story. See the STU:74C stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


CROSSJECT Business Description

Other Exchanges ALCJ:France
Address 60L avenue du 14 Juillet, Chenôve, FRA, 21300
CROSSJECT manufactures and markets needle-free drug self-injection system.
48GF Score

Get the complete analysis for STU:74C

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.77
Price
€1.18
GF Value